Clinical Trial Update: A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily [Phase 4]

View source ↗

Summary

A Phase 4 multicenter trial evaluating twice-daily versus once-daily topical treatment for papulopustular rosacea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papulopustular Rosacea

Snippet

Sponsor: LEO Pharma | Conditions: Papulopustular Rosacea | Phase 4 | Status: COMPLETED